# Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer

_Canadian Journal of Urology · Jingcheng Lyu, Ruiyu Yue, Yukun Liu et al. · 2026_

Canonical: https://diginpl.com/books/paper-cju-2026-084989
Last updated: 2026-10-02

## Quick facts

- **Author:** Jingcheng Lyu; Ruiyu Yue; Yukun Liu; Bo Song; Boyu Yang; Fengbo Zhang ([Crossref](https://doi.org/10.32604/cju.2026.084989))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/cju.2026.084989))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/cju.2026.084989))
- **Journal:** Canadian Journal of Urology ([Crossref](https://doi.org/10.32604/cju.2026.084989))
- **DOI:** 10.32604/cju.2026.084989 ([Crossref](https://doi.org/10.32604/cju.2026.084989))

## Questions

**Who wrote Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer?**  
Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer was written by Jingcheng Lyu, Ruiyu Yue, Yukun Liu, Bo Song.

**When was Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer first published?**  
Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/cju.2026.084989)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/cju.2026.084989.

## Cite this page

"Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-cju-2026-084989. Retrieved 14 November 2026.